Source:http://linkedlifedata.com/resource/pubmed/id/19631268
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2009-9-1
|
pubmed:abstractText |
Sustained oxidative stress is a known sequel to focal cerebral ischemia. This study examined the effects of treatment with a single dose or sustained infusion of the redox-modulating MnPorphyrin Mn(III)TDE-2-ImP(5+) on outcome from middle cerebral artery occlusion (MCAO) in the rat. Normothermic rats were subjected to 90 min MCAO followed by 90 min reperfusion and then were treated with a single intracerebroventricular dose of Mn(III)TDE-2-ImP(5+). Neurologic and histologic outcomes were assessed at 1 or 8 weeks postischemia. A single dose of Mn(III)TDE-2-ImP(5+) caused a dose-dependent improvement in histologic and neurologic outcome when assessed 1 week postischemia. Mn(III)TDE-2-ImP(5+) afforded preservation of brain aconitase activity at 5.5 h after reperfusion onset, consistent with its known antioxidant properties. Mn(III)TDE-2-ImP(5+) also attenuated postischemic NF-kappaB activation. Evidence for effects on cerebral infarct size and neurologic function had completely dissipated when rats were allowed to survive for 8 weeks postischemia. In contrast, a 1-week continuous intracerebroventricular Mn(III)TDE-2-ImP(5+) infusion caused persistent and substantive reduction in both cerebral infarct size and neurologic deficit at 8 weeks postischemia. Pharmacologic modulation of postischemic oxidative stress is likely to require sustained intervention for enduring efficacy in improving neurologic and histologic outcome from a transient focal ischemic insult.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aconitate Hydratase,
http://linkedlifedata.com/resource/pubmed/chemical/Metalloporphyrins,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/manganese (III)...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1873-4596
|
pubmed:author |
pubmed-author:Batinic-HaberleInesI,
pubmed-author:CrapoJames DJD,
pubmed-author:FukudaShiroS,
pubmed-author:JohnsonKwameK,
pubmed-author:PaschenWulfW,
pubmed-author:PearlsteinRobert DRD,
pubmed-author:PiganelliJonJ,
pubmed-author:ShengHuaxinH,
pubmed-author:TseHubert MHM,
pubmed-author:WarnerDavid SDS,
pubmed-author:YangWeiW
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
917-23
|
pubmed:dateRevised |
2011-9-26
|
pubmed:meshHeading |
pubmed-meshheading:19631268-Aconitate Hydratase,
pubmed-meshheading:19631268-Animals,
pubmed-meshheading:19631268-Disease Models, Animal,
pubmed-meshheading:19631268-Dose-Response Relationship, Drug,
pubmed-meshheading:19631268-Drug Administration Schedule,
pubmed-meshheading:19631268-Infarction, Middle Cerebral Artery,
pubmed-meshheading:19631268-Male,
pubmed-meshheading:19631268-Metalloporphyrins,
pubmed-meshheading:19631268-NF-kappa B,
pubmed-meshheading:19631268-Neuroprotective Agents,
pubmed-meshheading:19631268-Oxidation-Reduction,
pubmed-meshheading:19631268-Oxidative Stress,
pubmed-meshheading:19631268-Rats,
pubmed-meshheading:19631268-Rats, Wistar,
pubmed-meshheading:19631268-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Long-term neuroprotection from a potent redox-modulating metalloporphyrin in the rat.
|
pubmed:affiliation |
The Multidisciplinary Neuroprotection Laboratories, Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|